Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Britny R Brown

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Currents in Pharmacy Teaching & Learning|March 10, 2023
Creating an inclusive climate within pharmacy practiceKathleen K Adams, Britny R Brown
The American Journal of Managed Care|October 23, 2023
Association of guideline-concordant care with survival, health care utilization, and costs among older women with advanced epithelial ovarian cancerShweta Kamat, Britny R Brown, Anne Hume, et al.
Cancer Investigation|August 2, 2022
Adverse Events Induced by Nivolumab Plus Ipilimumab <i>vs.</i> Nivolumab Monotherapy among Cancer Patients: A Systematic Review and Meta-AnalysisShweta Kamat, Jay Patel, Britny R Brown, et al.
Journal of Managed Care & Specialty Pharmacy|February 4, 2026
Patient factors and costs associated with prophylactic neurokinin-1 receptor antagonist use among women with invasive breast cancerShweta Kamat, Britny R Brown, Steven A Cohen, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 19, 2022
Comparative cost savings of biosimilar and dose rounding utilization in oncology careVerona Abdelmeseh, Britny R Brown, Justin P Huynh, et al.
Health Services Research|April 14, 2025
Prophylactic Neurokinin-1 Receptor Antagonist Use Pre- and Post-Choosing Wisely Initiative Among Women With Invasive Breast CancerShweta Kamat, Britny R Brown, Steven A Cohen, et al.
JCO Oncology Practice|November 21, 2025
Characterizing Patient-Reported Outcome Data Availability for Oral Anticancer TherapiesBritny R Brown, Jessica Samuel, Morgan Teeters, et al.
Pharmacoepidemiology and Drug Safety|October 15, 2025
Diagnostic Performance of Prostate Cancer Disease-Specific Phenotypes Identified Using Real-World Databases: A Systematic ReviewAmi Vyas, Shweta Kamat, Sadie Thomas, et al.
Journal of the American Pharmacists Association : Japha|October 21, 2023
The implications of data aggregation on propagating racial and ethnic disparities within the health care landscape: Actionable recommendations and considerations for pharmacistsEmma Camara, Ana Safri, Caroline L Ko, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 29, 2026
HSR26-243: Real-World Persistence With CDK4/6 Inhibitors in Early and Metastatic HR-Positive, HER2-Negative Breast CancerGuannan Gong, Britny R Brown, Sameer Pandya, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Currents in Pharmacy Teaching & Learning|March 10, 2023
Creating an inclusive climate within pharmacy practiceKathleen K Adams, Britny R Brown
The American Journal of Managed Care|October 23, 2023
Association of guideline-concordant care with survival, health care utilization, and costs among older women with advanced epithelial ovarian cancerShweta Kamat, Britny R Brown, Anne Hume, et al.
Cancer Investigation|August 2, 2022
Adverse Events Induced by Nivolumab Plus Ipilimumab <i>vs.</i> Nivolumab Monotherapy among Cancer Patients: A Systematic Review and Meta-AnalysisShweta Kamat, Jay Patel, Britny R Brown, et al.
Journal of Managed Care & Specialty Pharmacy|February 4, 2026
Patient factors and costs associated with prophylactic neurokinin-1 receptor antagonist use among women with invasive breast cancerShweta Kamat, Britny R Brown, Steven A Cohen, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 19, 2022
Comparative cost savings of biosimilar and dose rounding utilization in oncology careVerona Abdelmeseh, Britny R Brown, Justin P Huynh, et al.
Health Services Research|April 14, 2025
Prophylactic Neurokinin-1 Receptor Antagonist Use Pre- and Post-Choosing Wisely Initiative Among Women With Invasive Breast CancerShweta Kamat, Britny R Brown, Steven A Cohen, et al.
JCO Oncology Practice|November 21, 2025
Characterizing Patient-Reported Outcome Data Availability for Oral Anticancer TherapiesBritny R Brown, Jessica Samuel, Morgan Teeters, et al.
Pharmacoepidemiology and Drug Safety|October 15, 2025
Diagnostic Performance of Prostate Cancer Disease-Specific Phenotypes Identified Using Real-World Databases: A Systematic ReviewAmi Vyas, Shweta Kamat, Sadie Thomas, et al.
Journal of the American Pharmacists Association : Japha|October 21, 2023
The implications of data aggregation on propagating racial and ethnic disparities within the health care landscape: Actionable recommendations and considerations for pharmacistsEmma Camara, Ana Safri, Caroline L Ko, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 29, 2026
HSR26-243: Real-World Persistence With CDK4/6 Inhibitors in Early and Metastatic HR-Positive, HER2-Negative Breast CancerGuannan Gong, Britny R Brown, Sameer Pandya, et al.
Pageof 2